TH
GSK icon

Timber Hill’s GSK GSK Stock Holding History

Timber Hill’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-8,400
Closed -$372K – 421
2017
Q4 		$372K Hold
8,400
– – 0.02% 444
2017
Q3 		$426K Buy
8,400
+400
+5% +$20.3K 0.04% 364
2017
Q2 		$431K Sell
8,000
-215,760
-96% -$11.5M 0.02% 613
2017
Q1 		$11.8M Sell
223,760
-204,000
-48% -$10.3M 0.09% 169
2016
Q4 		$20.6M Buy
427,760
+63,280
+17% +$3.13M 0.09% 171
2016
Q3 		$19.6M Buy
364,480
+92,480
+34% +$5.07M 0.09% 178
2016
Q2 		$14.7M Buy
272,000
+129,120
+90% +$6.8M 0.07% 239
2016
Q1 		$7.24M Sell
142,880
-59,200
-29% -$2.95M 0.03% 398
2015
Q4 		$10.2M Buy
202,080
+2,080
+1% +$106K 0.05% 311
2015
Q3 		$9.61M Sell
200,000
-45,680
-19% -$2.38M 0.04% 333
2015
Q2 		$12.8M Sell
245,680
-4,640
-2% -$261K 0.06% 287
2015
Q1 		$14.4M Buy
250,320
+26,000
+12% +$1.49M 0.07% 245
2014
Q4 		$12M Sell
224,320
-72,160
-24% -$4.04M 0.05% 291
2014
Q3 		$17M Sell
296,480
-6,880
-2% -$422K 0.07% 222
2014
Q2 		$20.3M Buy
303,360
+58,480
+24% +$3.96M 0.09% 175
2014
Q1 		$16.4M Buy
244,880
+22,000
+10% +$1.49M 0.07% 229
2013
Q4 		$14.9M Sell
222,880
-37,520
-14% -$2.43M 0.05% 294
2013
Q3 		$16.3M Sell
260,400
-39,040
-13% -$2.51M 0.06% 272
2013
Q2 		$18.7M Buy
+299,440
New +$19M 0.07% 234

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Timber Hill's GSK Position: Q4 2017 in Review

Timber Hill sold out of GSK (GSK) in Q4 2017, closing a stake of 22,265 shares — an estimated $1.03M sold.

Timber Hill first reported a position in GSK in Q2 2014 and held it in 7 quarters. The position peaked at $3.34M in Q3 2014. 763 funds tracked by Wall St. Rank hold GSK as of Q4 2017.

  • Timber Hill reported no remaining GSK position as of Q4 2017 after selling out during the quarter.
  • Timber Hill sold 22,265 GSK shares in Q4 2017, an estimated $1.03M.
  • Timber Hill first reported a position in GSK in Q2 2014 and held it in 7 quarters.
  • Timber Hill's GSK position peaked at $3.34M in Q3 2014.
  • 763 funds tracked by Wall St. Rank held GSK as of Q4 2017.

Based on Timber Hill's 13F filing for Q4 2017, filed 9 Feb 2018.